ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 Nuclear Energy Conference & Expo (NECX)
August 24–27, 2026
Dallas, TX|Hilton Anatole
Latest Magazine Issues
Jun 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
July 2026
Nuclear Technology
June 2026
Fusion Science and Technology
May 2026
Latest News
North American construction is back—smaller and faster—at OPG’s Darlington
“The nuclear renaissance is real here,” said Ontario Power Generation’s Subo Sinnathamby on May 8, one year to the day after OPG secured a final investment decision to build the first of four planned BWRX-300 reactors at its Darlington nuclear power plant, and shortly after the new reactor’s foundation was lifted into place. “We got our license to construct in April and our [final investment decision] in May, and we’ve been off to the races since.”
A. Melintescu, D. Galeriu
Fusion Science and Technology | Volume 54 | Number 1 | July 2008 | Pages 269-272
Technical Paper | Environment and Safety | doi.org/10.13182/FST08-A1810
Articles are hosted by Taylor and Francis Online.
In the frame of IAEA EMRAS (Environmental Modelling for Radiation Safety) programme, there was developed a scenario for models' testing starting with unpublished data for a sow fed with OBT for 84 days. The scenario includes model predictions for the dynamics of tritium in urine and faeces and HTO and OBT in organs at sacrifice. There have been done two inter-comparison exercises and most of the models succeeded to give predictions better than a factor 3 to 5, excepting faeces. There has been done an analysis of models' structure, performance and limits in order to be able to build a model of moderate complexity with a reliable predictive power, able to be applied for human dosimetry, also, when OBT data are missing.